 Press Release Distribution |
 |
- PR Home
- Latest News
- Feeds
- Alerts
- Submit Free Press Release
- Journalist Account
- PRNewswire Distribution
Filter News Show All ResultsNews By Country
News By Tag Otc:pwrm  Related Tags Alzheimer's
Bc-serapro Biomedical Biotechnology Dr. Ira L. Goldknopf Helen J. Park Helen R. Park Ira L. Goldknopf Justin Handy Nuropro Otc:prot Penny To Buck Power 3 Medical Products Power3 Power3 Medical Power3 Medical Products Prot.ob Pwrm Pwrm Ob Pwrm.ob
| otc:pwrm Latest News+ XML/RSSBy Karl McMahon Power3 Medical Products, Inc. (OTC.BB:PWRM) is a proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the early detection of breast cancer and neurological diseases. By Karl McMahon Helen R. Park, Hugh Hefner, NYSE:PLA, otc:pwrm, Playboy, power3 medical products, pwrm.ob By Karl McMahon Power3 Medical Products, Inc. (OTC.BB:PWRM) strives to become the premier biotechnology company specializing in the commercialization of proteomics IP for the diagnosis and treatment of disease by using cutting edge technologies VISN, PWRM, ORFG -Market Update From DrStockPick.com! (VisionChina Media, Power 3 Medical, Orofino G By Karl McMahon VisionChina Media Inc.(Nasdaq:VISN), one of China's largest out-of-home digital television advertising networks on mass transportation systems, and Focus Media Holding Limited By Karl McMahon Power3 Medical Products, Inc. (OTC.BB:PWRM) is a breakthrough proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the detection of breast cancer and neurological diseases. By Karl McMahon Power3 Medical Products, Inc. (OTC.BB:PWRM) is a leading edge biotechnology company engaged in the early detection, monitoring, and targeting of diseases through the analysis of proteins. By Karl McMahon Power3 Medical Products, Inc. (OTC.BB:PWRM) is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease. By Karl McMahon Power3 Medical Products, Inc. (OTC.BB:PWRM)a breakthrough proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the early detection of breast cancer and neurological diseases. By Greg Lumpkin Breast cancer rates now have fallen in recent times, even so medical professionals are not certain the key reason why. By Karl McMahon Power3 Medical Products, Inc. (OTC.BB:PWRM) a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, By Karl McMahon Power3 has filed several patent applications for its NuroPro® technology that are currently pending. By Greg Lumpkin PWRM pursues an aggressive intellectual property strategy to protect its inventions and discoveries made on its own and with its collaborators. By Karl McMahon Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases. By Karl McMahon Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases. By Karl McMahon Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, By Karl McMahon Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases. By Karl McMahon Power3 Medical Products, Inc. (OTC.BB:PWRM)delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (ICAD) in Honolulu, Hawaii. By Karl McMahon Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases. By Karl McMahon Northrop Grumman Corporation (NYSE:NOC) announced the donation of a robust geospatial data set and capability to the Boy Scouts of America in support of their 100th anniversary and to help further scouting education. By Karl McMahon Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases. By Karl McMahon Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases. By Karl McMahon Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases. By Blayne Sheffield PWRM.OB, HMA, RDN, & NVE: NV Energy, Inc. Reports Third Quarter Earnings By Blayne Sheffield Power3 has filed several patent applications for its NuroPro® technology that are currently pending. Power3 also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. NRO, ULU, SA, & PWRM.OB: Drills Upgrading Large Resource at Seabridge Gold's Courageous Lake Project By Blayne Sheffield NRO, ULU, SA, & PWRM.OB: Drills Upgrading Large Resource at Seabridge Gold's Courageous Lake Project By Lynnette Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases By Justin Handy Stock Update On PWRM, TAXS, USB for August 31st, 2010 from PennyToBuck.com By Justin Handy Stock Highlight from PennyTOBuck on PROT, PWRM, ABT for Ausut 30th, 2010. By Justin Handy Stock Highlight On GENZ, PWRM, ENZ from PennytoBuck.com By Justin Handy PennyToBuck Stock Updates on PWRM, HLF, STEM for August 26th, 2010 By Justin Handy PennyToBuck stock update on TAXS, JTX,PWRM,VRML and MRK. By Hanson Power3 Medical Products (OTCBB: PWRM.OB) BC-SeraPro™ was developed and its performance characteristics determined by the Power3 Medical Products Laboratories. By Justin Handy KERX, a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases. By Justin Handy MRK reported that two pivotal Phase III registration studies for boceprevir, its investigational oral hepatitis C protease inhibitor. By Blayne Sheffield PWRM.OB, ILMN, & VSYM.OB: ILMN has recently reported the production of the Eco Real-Time PCR System By Blayne Sheffield PWRM, MNTA, & SNY: Raul E. Kohan will be appointed Chief Executive Officer By Justin Handy LLY stated that the U.S. Court of Appeals for the Federal Circuit has upheld a prior ruling that that Gemzar's method-of-use patent is invalid. By Justin Handy PWRM.ob has filed for patent protection for these findings and will be publishing these seminal results in the near future in one of the world’s most prestigious peer-reviewed scientific journals. By Blayne Sheffield MNTA, GENZ, & PWRM.OB: Biotech Stocks: Onyx, Genzyme, Momenta in spotlight By DrStockPick Power3 Medical Products, Inc. (OTCBB:PWRM.OB) strives to become the premier biotechnology company specializing in the commercialization of proteomics IP for the diagnosis and treatment of disease by using cutting edge technologies. By DrStockPick Power3 Medical Products is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. By Blayne Sheffield GENZ, PWRM, & SNY: Blink on Friday And Miss Massive Biotech Spikes By Blayne Sheffield PWRM, ILMN, & CAH: Sequenom Rises as Ladenburg Says Buy, Jefferies Starts at Hold By Blayne Sheffield AFFX, LIFE, & OTC:PWRM: Affymetrix Launches Axiom Custom Genotyping Arrays Utilizing World's Largest Validated SNP Database By Blayne Sheffield SNY, GSK, & OTC:PWRM: Weekly Pharma Roundup: GSK Settles, Vivus Disappoints, Ely Lilly Axes By Lynn Lansky Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, recently announced that Glucose RapidSpray, is now available under a trial run at selected Boots UK retail chain stores. Molecular Insight Receives Fifth Extension of Waiver Agreement with Bond Holders: MIPI, PWRM, & SIGA By Blayne Sheffield Molecular Insight Pharmaceuticals is a clinical-stage biopharmaceutical company and a pioneer in the emerging field of molecular medicine. The Company is focused on the discovery. By Lynn Lansky Power3 Medical Products (OTCBB: PWRM.OB) business focus is the development of commercial applications for their proprietary technologies. | ||||||||||||||||||||||
Like PRLog?
8.4K1.9K2.6K